BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • BioTech Events
  • BioTech Company Directory
  • Contact Us
Archives
  • September 2022
  • August 2022
  • July 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • BioTech Events
  • BioTech Company Directory
  • Contact Us

Month: May 2021

7 posts
Ministry of Food Drug Safety of South Korea Moderna COVID 19 Vaccine
BioTech Health X
  • May 21, 2021

Biotech NewsModerna Announces Ministry of Food and Drug Safety of South Korea (MFDS) COVID-19 Authorization

  • 2 minute read
Moderna, Inc., (NASDAQ: MRNA) has recently been authorized by the Ministry of Food and Drug Safety of South…
0 Shares
0
0
0
0
0
0
0
NTx Hires Bristol-Myers Squibb Veteran Biopharma Executive Nancy Rurkowski to Join its Board of Directors
BioTech Health X
  • May 15, 2021

Biotech NewsNTx Hires Bristol-Myers Squibb Veteran Biopharma Executive Nancy Rurkowski to Join its Board of Directors

  • 2 minute read
The 35-year veteran of Bristol-Myers Squibb brings manufacturing operations and product launch leadership expertise to drive NTx commercialization…
0 Shares
0
0
0
0
0
0
0
COVID-19 Rocks Yankees, 8th Vaccinated Member to Test Positive - Virology Experts Weigh In
BioTech Health X
  • May 14, 2021

Biotech NewsCOVID-19 Rocks Yankees, 8th Vaccinated Member to Test Positive – Virology Experts Weigh In

  • 3 minute read
Professional Major League Baseball organization the New York Yankees have been rocked this week with COVID-19 after 8…
0 Shares
0
0
0
0
0
0
0
Capricor CEO to Present at American Society of Gene and Cell Therapy Annual Meeting Ahead of Q1 Earnings Update
BioTech Health X
  • May 13, 2021

Biotech NewsCapricor CEO to Present at American Society of Gene and Cell Therapy Annual Meeting Ahead of Q1 Earnings Update

  • 3 minute read
May 13 is a busy day for biotechnology company Capricor Therapeutics (NASDAQ: CAPR). The company which focuses on…
0 Shares
0
0
0
0
0
0
0
maxwell-biosciences-makers-of-claromer-hire-john-lord-ph-d-as-vp-of-research-and-development
BioTech Health X
  • May 7, 2021

Biotech NewsMaxwell Biosciences, Makers of CLAROMER, Hire John Lord, Ph.D., as VP of Research and Development

  • 2 minute read
Austin, Texas based biotechnology company Maxwell Biosciences have announced the hiring of Dr. John Lord as Vice President…
0 Shares
0
0
0
0
0
0
0
Aerobiotix Announces Raise of $25M Growth Equity Financing Led by Healthcare Investment Firm Vivo Capital
Jak Thomson
  • May 6, 2021

Biotech NewsAerobiotix Announces Raise of $25M Growth Equity Financing Led by Healthcare Investment Firm Vivo Capital

  • 3 minute read
Aerobiotix, a pioneer in airborne infection control products that provide real-time, in room solutions for hospitals, ASCs, long…
0 Shares
0
0
0
0
0
0
0
Repertoire Immune Medicines Enters Collaboration with Yale to Research Multiple Sclerosis Novel Antigen Discovery T Cell Receptors
BioTech Health X
  • May 4, 2021

Biotech NewsRepertoire Immune Medicines Enters Collaboration with Yale to Research Multiple Sclerosis Novel Antigen Discovery & T Cell Receptors

  • 3 minute read
The collaboration between Repertoire and Yale seeks to identify novel antigenic reactivity of T cells in patients with…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • Virios Therapeutics Stock Plunges 70% on Fibromyalgia Clinical Trial Failure Results
  • CEL-SCI Multikine Phase 3 Data Highlighted at ESMO 2022
  • Mayo Clinic, Hibiscus BioVentures, and Innoforce Announce Mayflower Cell and Gene Therapy Accelerator
  • SyneuRx CEO Dr. Emil Tsai Exclusive Interview with Insights & Projections
  • Krystal Biotech Announces FDA IND Acceptance for KB407 Cystic Fibrosis Clinical Trial
Recent Comments
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • September 19, 2022
    Virios Therapeutics Stock Plunges 70% on Fibromyalgia Clinical Trial Failure Results
    Virios-Therapeutics-Stock-Plunges-70-on-Fibromyalgia-Clinical-Trial-Failure-Results
    • September 14, 2022
    CEL-SCI Multikine Phase 3 Data Highlighted at ESMO 2022
    CEL-SCI Multikine Phase 3 Data Highlighted at ESMO 2022
    • September 3, 2022
    Mayo Clinic, Hibiscus BioVentures, and Innoforce Announce Mayflower Cell and Gene Therapy Accelerator
    Mayo-Clinic-Gene-Accelerator
    • September 2, 2022
    SyneuRx CEO Dr. Emil Tsai Exclusive Interview with Insights & Projections
    SyneuRx CEO Interview Dr Emil Tsai BioTech Health X
    • August 1, 2022
    Krystal Biotech Announces FDA IND Acceptance for KB407 Cystic Fibrosis Clinical Trial
    Krystal Biotech Announces FDA IND Acceptance for KB407 Cystic Fibrosis Clinical Trial
Recent Posts
  • ImmunityBio Announces FDA Acceptance of BLA for N-803 Anktiva Bladder Cancer Drug
    ImmunityBio Announces FDA Acceptance of BLA for N-803 Anktiva Bladder Cancer Drug
    • July 28, 2022
  • Brickell Biotech Regains Nasdaq Compliance Meeting Minimum Bid Price Requirement
    Brickell Biotech Regains Nasdaq Compliance Meeting Minimum Bid Price Requirement
    • July 22, 2022
  • Merck Announces Failure in Keytruda Head and Neck Cancer Phase 3 Clinical Trial
    Merck Announces Failure in Keytruda Head and Neck Cancer Phase 3 Clinical Trial
    • July 20, 2022
Categories
  • BioTech CEO Interviews (4)
  • Biotech News (44)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by Code Supply Co.
  • Our Contributors
  • List of Modern Life Science Technologies
  • Contact Us
Back to top